Showing results (301-310 of 310) with videos related to
Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 310 results.
International Journal of Radiation Oncology, Biology, Physics|October 5, 2021
Radiation Therapy Techniques and Treatment-Related Toxicity in the PORTEC-3 Trial: Comparison of 3-Dimensional Conformal Radiation Therapy Versus Intensity-Modulated Radiation TherapyBastiaan G Wortman, Cathalijne C B Post, Melanie E Powell, et al.Plos One|February 9, 2026
Study protocol for a multicenter phase II prospective externally controlled non-inferiority trial of hypofractionated re-irradiation in patients with recurrent high-grade glioma (RISinG)A M de Jong, A T J van der Boog, C C B Post, et al.European Journal of Cancer (Oxford, England : 1990)|June 19, 2026
No prognostic role for FIGO grading in mismatch repair deficient endometrial carcinomaFamke C Wakkerman, Cathalijne C B Post, Gitte Ørtoft, et al.Journal of the National Cancer Institute|March 11, 2021
Prevalence and Prognosis of Lynch Syndrome and Sporadic Mismatch Repair Deficiency in Endometrial CancerCathalijne C B Post, Ellen Stelloo, Vincent T H B M Smit, et al.Maturitas|December 6, 2025
Age-related differences in patient preferences for adjuvant chemotherapy for high-risk endometrial cancerFamke C Wakkerman, Cathalijne C B Post, Jan Willem M Mens, et al.Obstetrical & Gynecological Survey|December 30, 2025
Adjuvant Chemoradiotherapy Versus Radiotherapy Alone in Women With High-Risk Endometrial Cancer (PORTEC-3): 10-Year Clinical Outcomes and Post Hoc Analysis by Molecular Classification From a Randomized Phase 3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.The Lancet. Oncology|September 8, 2025
Adjuvant chemoradiotherapy versus radiotherapy alone in women with high-risk endometrial cancer (PORTEC-3): 10-year clinical outcomes and post-hoc analysis by molecular classification from a randomised phase 3 trialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.Journal of Computational Chemistry|May 16, 2009
CHARMM: the biomolecular simulation programB R Brooks, C L Brooks, A D Mackerell, et al.International Journal of Radiation Oncology, Biology, Physics|November 1, 2020
Long-Term Toxicity and Health-Related Quality of Life After Adjuvant Chemoradiation Therapy or Radiation Therapy Alone for High-Risk Endometrial Cancer in the Randomized PORTEC-3 TrialCathalijne C B Post, Stephanie M de Boer, Melanie E Powell, et al.The New England Journal of Medicine|February 15, 2013
Neurostimulation for Parkinson's disease with early motor complicationsW M M Schuepbach, J Rau, K Knudsen, et al.Pageof 31